BridgeMD
Tests treatment safety and results for Intubation
Official title Comparative Efficacy of Intravenous Labetalol and Lignocaine in Mitigating Hemodynamic Responses to Laryngoscopy During Laparoscopic Cholecystectomy
ClinicalTrials.gov ID: NCT07192081
What this study is testing
What is Labetalol?
Labetalol is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for intubation.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Laryngoscopy and intubation during laparoscopic cholecystectomy often cause sudden increases in heart rate and blood pressure, which can be harmful in some patients. Medications such as labetalol and lignocaine are commonly used to reduce this hemodynamic response.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- ASA Grade I and II
- Age 18 to 60 years
- Elective laparoscopic cholecystectomy
- Both genders
- Informed consent given
You likely can't join if
- Hypersensitivity to labetalol/lignocaine
- Hypertensive on antihypertensives
- ASA Grade III or more
- Cardiovascular, renal, hepatic, or endocrine issues
- Pregnant/lactating
- BMI ≥ 35
See the full eligibility criteria
- ASA Grade I and II
- Age 18 to 60 years
- Elective laparoscopic cholecystectomy
- Both genders
- Informed consent given
- Hypersensitivity to labetalol/lignocaine
- Hypertensive on antihypertensives
- ASA Grade III or more
- Cardiovascular, renal, hepatic, or endocrine issues
- Pregnant/lactating
- BMI ≥ 35
- Anticipated difficult airway
The study team makes the final eligibility decision.
Where it's taking place
- Peshawar, Khyber Pakhtunkhwa, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Peshawar, Khyber Pakhtunkhwa, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.